A couple
of days ago I said “I do like the “Transfusion News” updates. They don’t
swamp me with information, and they are regular. Little and often – as CPD
should be…”
Today I
got the Stem Cell Evidence Alert… I don’t get them very often, and when I do my
poor brain overloads…
ARTICLE OF THE MONTH HLA Haploidentical versus Matched Unrelated Donor Transplants with Post-Transplant Cyclophosphamide based prophylaxis. +++++ |
SELECTED ARTICLES
Immune
Reconstitution Following TCRaß/CD19-Depleted Hematopoietic Cell
Transplantation for Hematologic Malignancy in Pediatric Patients.
Arnold, D. E., et al. (2021) Transplantation and Cellular Therapy 27(2):169.e1-169.e9
Excellent
overall and chronic graft-versus-host-disease-free event-free survival
in Fanconi anaemia patients undergoing matched related- and
unrelated-donor bone marrow transplantation using alemtuzumab-Flu-Cy:
the UK experience.
Bernard, F., et al. (2021) British Journal of Haematology [record in progress].
Multicenter
Phase II Study on Haploidentical Bone Marrow Transplantation Using a
Reduced-Intensity Conditioning Regimen and Posttransplantation
Cyclophosphamide in Patients with Poor-Prognosis Lymphomas
Castagna, L. et al. (2021) Transplantation and Cellular Therapy27(4):328.e1-328.e6
Feasibility
and Efficacy of CD45RA+ Depleted Donor Lymphocytes Infusion After
Haploidentical Transplantation With Post-Transplantation
Cyclophosphamide in Patients With Hematological Malignancies.
Castagna, L. et al. (2021) Transplantation and Cellular Therapy [record in progress]
Phase I Dose-Finding, Safety, and Tolerability Trial of Romiplostim to Improve Platelet Recovery After UCB Transplantation.
Christakopoulos, G. E., et al. (2021) Transplantation and Cellular Therapy [record in progress]
Second
allogeneic haematopoietic cell transplantation using HLA-matched
unrelated versus T-cell replete haploidentical donor and survival in
relapsed acute myeloid leukaemia.
Kharfan-Dabaja, M. A., et al. (2021) British Journal of Haematology [record in progress].
Comparison
of immune reconstitution between anti-T-lymphocyte globulin and
post-transplant cyclophosphamide as acute graft-versus-host disease
prophylaxis in allogeneic myeloablative peripheral blood stem cell
transplantation.
Massoud, R., et al. (2021) Haematologica [record in progress].
Impact
of Previously Unrecognized HLA Mismatches Using Ultrahigh Resolution
Typing in Unrelated Donor Hematopoietic Cell Transplantation.
Mayor, N. P., et al. (2021) Journal of Clinical Oncology [record in progress].
Myeloablative
versus Reduced-Intensity Conditioning for Hematopoietic Cell
Transplantation in Acute Myelogenous Leukemia and Myelodysplastic
Syndromes-Long-Term Follow-Up of the BMT CTN 0901 Clinical Trial
Scott, B. L., et al. (2021) Transplantation and Cellular Therapy [record in progress].
No comments:
Post a Comment